This brochure presents Clario’s comprehensive cardiac safety solutions designed to reduce risk across all phases of clinical development. It emphasizes centralized ECG data collection, standardized assessments, and real-time trial visibility to address cardiac safety issues that frequently delay or derail drug development. The document details early- and late-phase solutions such as EPQT and SafePatient ECG, supported by Clario’s EXPERT® platform. It highlights Clario’s extensive experience, including over 19,000 trials, millions of patients, and hundreds of regulatory approvals. Performance metrics such as on-time data delivery, equipment shipment reliability, and ECG quality reinforce operational excellence. Overall, the brochure positions Clario as a global leader in cardiac safety, com

Join for free to read